Since the start of the pandemic, the U.S. government has allocated over $34 billon to improve U.S. medicines supply chain resilience.
An all-too-familiar experience in recent years, medicines supply chain disruptions can arise from many factors, including pandemics like COVID-19, natural disasters, and geopolitical events like those taking place right now in Eastern Europe.
While USP is most well-known for its quality standards for medicines and their ingredients, USP also has initiatives focused on food ingredients, dietary supplements and other areas associated with the global supply of medicines. In celebration of World Quality Month, read more about USP's efforts related to product quality and standards.
Mandela Washington Fellow, Dr. Ashiru Abubakar, talks with USP about the drug supply chain, the intersection of public health and political will, and the hope for a future free of counterfeit medicines in his native Nigeria.
Here in the United States, we enjoy one of the safest drug and food supplies in the world. It is a huge accomplishment, and the result of a vast safety net created by the coordinated efforts of multiple government agencies, health organizations, industry and non-profits. This article explains the role they play in ensuring that drug, drug ingredients, dietary supplements and food ingredients sold in the U.S. can be safely consumed.
